US5047533A
(en)
*
|
1983-05-24 |
1991-09-10 |
Sri International |
Acyclic purine phosphonate nucleotide analogs
|
US4845084A
(en)
*
|
1984-01-26 |
1989-07-04 |
Merck & Co., Inc. |
Phosphate derivatives of substituted butyl guanines, antiviral compositions containing them, and methods of treating viral infections with them
|
CS264222B1
(en)
*
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
US5650510A
(en)
*
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
AU613592B2
(en)
*
|
1986-11-18 |
1991-08-08 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
|
US5247085A
(en)
*
|
1987-11-30 |
1993-09-21 |
Beecham Group P.L.C. |
Antiviral purine compounds
|
NZ227104A
(en)
*
|
1987-11-30 |
1991-11-26 |
Beecham Group Plc |
Phosphorus-substituted purine derivatives and pharmaceutical compositions
|
EP0339161A1
(en)
*
|
1988-04-01 |
1989-11-02 |
Merrell Dow Pharmaceuticals Inc. |
Novel fluorophosphonate nucleotide derivatives
|
EP0335770B1
(en)
*
|
1988-04-01 |
1997-01-15 |
Merrell Pharmaceuticals Inc. |
Novel fluorophosphonate nucleotide derivatives
|
US5284837A
(en)
*
|
1988-05-06 |
1994-02-08 |
Medivir Ab |
Derivatives of purine, process for their preparation and a pharmaceutical preparation
|
EP0353955A3
(en)
*
|
1988-08-02 |
1991-08-14 |
Beecham Group Plc |
Novel compounds
|
US5744600A
(en)
*
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
US4966895A
(en)
*
|
1989-02-02 |
1990-10-30 |
Merck & Co. Inc. |
Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
|
US5688778A
(en)
*
|
1989-05-15 |
1997-11-18 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Nucleoside analogs
|
GB8912043D0
(en)
*
|
1989-05-25 |
1989-07-12 |
Beecham Group Plc |
Novel compounds
|
US5302585A
(en)
*
|
1990-04-20 |
1994-04-12 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
|
CS387190A3
(en)
*
|
1990-08-06 |
1992-03-18 |
Ustav Organicke Chemie A Bioch |
(2r)-2-/di(2-propyl)phosphonylmethoxy/-3-p-toluenesulfonyloxy -1- trimethylacetoxypropane and process for preparing thereof
|
EP0574386B1
(en)
*
|
1990-08-10 |
2000-06-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Novel process for the preparation of nucleotides
|
DE69129650T2
(de)
*
|
1990-09-14 |
1999-03-25 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic, Prag/Praha |
Wirkstoffvorläufer von Phosphonaten
|
US5208221A
(en)
*
|
1990-11-29 |
1993-05-04 |
Bristol-Myers Squibb Company |
Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5514798A
(en)
*
|
1993-06-02 |
1996-05-07 |
Gilead Sciences, Inc. |
Method and cyclic carbonates for nucleotide analogues
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
CA2171868A1
(en)
*
|
1993-09-17 |
1995-03-23 |
Petr Alexander |
Method for dosing therapeutic compounds
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
DE4408534A1
(de)
*
|
1994-03-14 |
1995-09-28 |
Hoechst Ag |
Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden
|
US6465650B1
(en)
|
1995-03-13 |
2002-10-15 |
Aventis Pharma Deutschland Gmbh |
Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
|
US5977061A
(en)
*
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5877166A
(en)
*
|
1996-04-29 |
1999-03-02 |
Sri International |
Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
|
US5733788A
(en)
*
|
1996-07-26 |
1998-03-31 |
Gilead Sciences, Inc. |
PMPA preparation
|
DE122005000041I2
(de)
*
|
1996-07-26 |
2012-05-24 |
Gilead Sciences Inc |
Nukleotidanaloga.
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
SG106656A1
(en)
*
|
1997-07-25 |
2004-10-29 |
Gilead Sciences Inc |
Nucleotide analog composition and synthesis method
|
WO2000029414A1
(fr)
*
|
1998-11-18 |
2000-05-25 |
Viktor Veniaminovich Tets |
Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methylphosphonates
|
US7205404B1
(en)
*
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
AU2001282941C1
(en)
|
2000-07-21 |
2016-12-22 |
Gilead Sciences, Inc. |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
|
BRPI0210746B8
(pt)
*
|
2001-06-29 |
2021-05-25 |
Inst Of Organic Chemistry And Biochemistry Ascr |
derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
|
HUP0501070A2
(en)
*
|
2001-11-14 |
2006-04-28 |
Biocryst Pharmaceuticals |
Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
|
US7388002B2
(en)
|
2001-11-14 |
2008-06-17 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
EP1532157A4
(en)
*
|
2002-05-13 |
2009-02-25 |
Metabasis Therapeutics Inc |
NEW PRODRUGS FROM PMEA TO PHOSPHONIC ACID BASE AND ITS ANALOG
|
US7193081B2
(en)
*
|
2002-05-13 |
2007-03-20 |
Metabasis Therapeutics, Inc. |
Process for preparation of cyclic prodrugs of PMEA and PMPA
|
KR101101962B1
(ko)
*
|
2002-11-12 |
2012-01-02 |
티안진 디실리 인베스트먼트 홀딩 그룹, 리미티드 |
새로운 결정 형태를 가진 아데포비어 디피복실의 제조 방법
|
EA015145B1
(ru)
*
|
2003-01-14 |
2011-06-30 |
Джилид Сайэнс, Инк. |
Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции
|
WO2004111064A1
(en)
*
|
2003-06-16 |
2004-12-23 |
Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic |
Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
|
US7579332B2
(en)
*
|
2003-07-30 |
2009-08-25 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
KR20070029196A
(ko)
*
|
2004-06-08 |
2007-03-13 |
메타베이시스 테라퓨틱스, 인크. |
고리 에스테르의 루이스 산 매개 합성
|
CN100338080C
(zh)
*
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
ES2401285T3
(es)
|
2004-12-16 |
2013-04-18 |
The Regents Of The University Of California |
Fármacos con el pulmón como diana
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
TWI375560B
(en)
*
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
EP2305695A3
(en)
|
2005-07-25 |
2011-07-27 |
Intermune, Inc. |
Macrocyclic inhibitors of Hepatitis C virus replication
|
WO2007013085A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Hetero Drugs Limited |
Novel process for acyclic phosphonate nucleotide analogs
|
MX2008004754A
(es)
*
|
2005-10-11 |
2009-03-02 |
Intermune Inc |
Compuestos y metodos para inhibir la replicacion viral de hepatitis c.
|
SI2051703T1
(sl)
*
|
2005-12-14 |
2011-01-31 |
Cipla Ltd |
Farmacevtski sestavki, ki vsebujejo inhibitorje nukleotidne in nukleozidne reverzne transkriptaze (kot tenofovir in lamivudin) v različnih delih dozirne oblike
|
FR2908133B1
(fr)
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
KR101173892B1
(ko)
|
2007-06-18 |
2012-08-16 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
브로모-페닐 치환된 티아졸릴 디하이드로피리미딘
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
US20110059921A1
(en)
*
|
2008-03-27 |
2011-03-10 |
Ektar Therapeutics |
Oligomer-Nitrogenous Base Conjugates
|
US7935817B2
(en)
*
|
2008-03-31 |
2011-05-03 |
Apotex Pharmachem Inc. |
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
|
US8048862B2
(en)
*
|
2008-04-15 |
2011-11-01 |
Intermune, Inc. |
Macrocyclic inhibitors of hepatitis C virus replication
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
TW201010692A
(en)
|
2008-06-19 |
2010-03-16 |
Public Univ Corp Nagoya City Univ |
Pharmaceutical composition for treatment or prevention of hbv infection
|
WO2010045266A1
(en)
*
|
2008-10-15 |
2010-04-22 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
WO2010075554A1
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Synthesis of purine nucleosides
|
CN102753563A
(zh)
|
2008-12-23 |
2012-10-24 |
吉利德制药有限责任公司 |
核苷类似物
|
PA8855601A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Forformidatos de nucleósidos
|
CN102365283B
(zh)
|
2009-03-26 |
2014-04-09 |
株式会社大熊制药 |
阿德福韦酯的新晶型及其制备方法
|
AU2010298028A1
(en)
*
|
2009-09-28 |
2012-04-19 |
Intermune, Inc. |
Cyclic peptide inhibitors of hepatitis C virus replication
|
US20110082182A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
JP6058528B2
(ja)
|
2010-03-31 |
2017-01-11 |
ギリアド ファーマセット エルエルシー |
ヌクレオシドホスホルアミデート
|
US20130115237A1
(en)
|
2010-06-09 |
2013-05-09 |
Vaccine Technologies, Incorporated |
Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
|
US20130216590A1
(en)
|
2010-06-11 |
2013-08-22 |
Quarraisha Abdool Karim |
Topical antiviral formulations for prevention of transmission of hsv-2
|
RU2606845C2
(ru)
|
2010-12-10 |
2017-01-10 |
СИГМАФАРМ ЛЭБОРЭТОРИЗ, ЭлЭлСи |
Высокостабильные композиции перорально активных аналогов нуклеотидов или перорально активных пролекарств аналогов нуклеотидов
|
US9550803B2
(en)
*
|
2011-05-06 |
2017-01-24 |
University Of Southern California |
Method to improve antiviral activity of nucleotide analogue drugs
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
WO2014068265A1
(en)
|
2012-10-29 |
2014-05-08 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
CN108619161A
(zh)
|
2013-03-15 |
2018-10-09 |
加利福尼亚大学董事会 |
无环核苷膦酸二酯
|
JP2017512183A
(ja)
|
2014-02-13 |
2017-05-18 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
US10167302B2
(en)
*
|
2014-05-23 |
2019-01-01 |
University College Cork |
Phosphonate nucleosides useful in the treatment of viral diseases
|
JP2017520545A
(ja)
|
2014-07-02 |
2017-07-27 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
CA2961200C
(en)
|
2014-09-15 |
2023-09-05 |
The Regents Of The University Of California |
Nucleotide analogs
|
EP3350191B9
(en)
|
2015-09-15 |
2021-12-22 |
The Regents of the University of California |
Nucleotide analogs
|
EP3372227A1
(en)
|
2017-03-06 |
2018-09-12 |
MH10 Spolka z ograniczona odpowiedzialnoscia |
Tablet formulation of adefovir dipivoxil
|
EP3737676B1
(en)
|
2018-01-09 |
2024-03-06 |
Ligand Pharmaceuticals, Inc. |
Acetal compounds and therapeutic uses thereof
|